Skip to main content
. 2019 Sep 3;28(5):2331–2338. doi: 10.1007/s00520-019-05029-z

Table 1.

Background of patients, physicians, and nurses

n (%)
Patients 207
  Age
    30 years and younger 20 (9.7)
    40 years 69 (33.3)
    50 years 86 (41.5)
    60 years and older 32 (15.5)
  Breast cancer subtypes
    HR-positive/HER2-positive 69 (33.3)
    HR-positive/HER2-negative 51 (24.6)
    HR-negative/HER2-positive 28 (13.5)
    HR-negative/HER2-negative 28 (13.5)
    Unknown 31 (15.0)
  Breast cancer status
    Operated, without recurrence/metastasis 162 (78.3)
    Operated, with recurrence/metastasis 37 (17.9)
    Unoperated, without recurrence/metastasis 3 (1.4)
    Unoperated, with recurrence/metastasis 5 (2.4)
  Drug therapy
    Chemotherapy 195 (94.2)
    Hormonal therapy 132 (63.8)
    Targeted therapy 61 (29.5)
Physicians 185
  Departments
    Department of breast oncology/surgery 81 (43.8)
    Department of general surgery 81 (43.8)
    Department of oncology 23 (12.4)
  Affiliated institutions
    University hospitals 45 (24.3)
    Designated cancer care hospitals 54 (29.2)
    General hospitals 78 (42.2)
    Other 8 (4.3)
Nursesa 150
  Hospital wards 67 (44.7)
  General outpatient units 48 (32.0)
  Outpatient chemotherapy units 45 (30.0)
  Breast cancer outpatient units 13 (8.7)
  Home visit nursing 6 (4.0)

Numbers in italics represent the total number of participants in each group

aSome nurses had more than one affiliation; hence, the numbers by affiliation type were summed to more than 150